Earningsreport

Q1/2024 3/31/2024 EPS -0.410 ZacksConsensus -0.410 ActVsEst 0.000 - In-Line

C4 Therapeutics, Inc.  (CCCC) 
NASDAQ:AMEX Investor Relations: ir.chinacache.com